Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite

  • ID: 4457195
  • Report
  • Region: Europe
  • 877 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Alphatec Spine
  • Croma-Pharma
  • Fidia
  • Laboratoire Genevrier
  • Orotech
  • Sanofi Genzyme
  • MORE
General Report Contents
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Lack of reimbursements can limit the European orthopedic biomaterials market. When a product is reimbursed, it is more readily adopted. For instance, in the hyaluronic acid market, most products are classified as medical devices and thus are not eligible for reimbursement. Only a few premium products under the umbrella of pharmaceuticals are reimbursed by the government or healthcare organizations. In addition to not being as well received as reimbursed products, the lack of reimbursement drives pricing down in an effort to make them more affordable. This price deterioration will have a negative impact on the market, as it may not be economically feasible for certain competitors to penetrate a market with low ASPs.

Unlike donated material, synthetic bone graft materials do not carry the risk of disease transmission, nor will they generate an immunogenic response in the recipient. As with allograft, the use of synthetic materials avoids the need for a second bone harvesting procedure. These products have been steadily reducing the amount of autograft bone that doctors have been using. Popularity of synthetics due to the affordability and easy accessibility, synthetic products are becoming the preferred products over allografts, DBMs and autografts. A wide range of synthetic products can offer flexibility and variety for different groups of patients. People in general are becoming more knowledgeable and accepting of synthetic products.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alphatec Spine
  • Croma-Pharma
  • Fidia
  • Laboratoire Genevrier
  • Orotech
  • Sanofi Genzyme
  • MORE
Executive Summary
European Orthopedic Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Country Profiles
2.1 Introduction
2.2 Germany
2.3 France
2.4 United Kingdom
2.5 Italy
2.6 Spain
2.7 Benelux
2.8 Scandinavia
2.9 Austria
2.10 Switzerland
2.11 Portugal

3. European Orthopedic Biomaterials Market Overview
3.1 Introduction
3.1.1 Bone Graft Substitutes
3.1.2 Growth Factors
3.1.3 Hyaluronic Acid Viscosupplementation
3.1.4 Autologous Chondrocyte Implantation
3.1.5 Cell Therapies
3.2 Currency Exchange Rate
3.3 Market Overview
3.4 Trend Analysis By Segment
3.5 Drivers and Limiters
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 Competitive Market Share Analysis
3.7 Mergers and Acquisitions

4. Procedure Numbers
4.1 Procedure Definitions
4.2 Bone Graft Procedure Numbers By Type
4.3 Bone Graft Substitute Procedure Numbers
4.3.1 By Material
4.3.2 By Indication
4.4 Growth Factor Bone Graft Procedure Numbers
4.5 Cell Therapy Treatment Numbers
4.5.1 Overview By Type
4.5.2 Platelet-Rich Treatment Numbers By Indication
4.5.3 Platelet-Rich Treatment Numbers By Indication
4.6 Hyaluronic Acid Treatment Numbers By Type
4.7 Cartilage Repair Procedure Numbers By Type
4.8 Spinal Machined Bone Allograft Procedure Numbers By Approach

5. Bone Graft Substitutes Market
5.1 Introduction
5.1.1 Units Per Procedure By Indication
5.2 Market Overview
5.2.1 Bone Graft Substitute Market By Material
5.2.2 Bone Graft Substitute Market By Indication
5.3 Market Analysis and Forecast
5.3.1 Total Bone Graft Substitute Market
5.3.2 Total Allograft Bone Graft Substitute Market
5.3.2.1 Total Allograft Spine Market
5.3.2.1.1 Allograft Cervical Spine Market
5.3.2.1.2 Allograft Thoracolumbar Spine Market
5.3.2.2 Allograft Trauma and Reconstruction Market
5.3.2.3 Allograft Craniomaxillofacial Market
5.3.3 Total Synthetic Bone Graft Substitute Market
5.3.3.1 Total Synthetic Spine Market
5.3.3.1.1 Synthetic Cervical Spine Market
5.3.3.1.2 Synthetic Thoracolumbar Spine Market
5.3.3.2 Synthetic Trauma and Reconstruction Market
5.3.3.3 Synthetic Craniomaxillofacial Market
5.3.4 Total Demineralized Bone Graft Substitute Bone Matrix Market
5.3.4.1 Total Demineralized Bone Matrix Spine Market
5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market
5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market
5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market
5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

6. Hyaluronic Acid Viscosupplementation Market
6.1 Introduction
6.1.1 Benefits of Viscosupplementation
6.1.2 Synovial Fluid
6.1.3 Treatment Types
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Hyaluronic Acid Viscosupplementation Market
6.3.1.1 Single-Injection Market
6.3.1.2 Three-Injection Market
6.3.1.3 Five-Injection Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

7. Bone Morphogenetic Protein Growth Factor Therapy Market
7.1 Introduction
7.2 Market Analysis and Forecast
7.3 Drivers and Limiters
7.3.1.1 Market Drivers
7.3.1.2 Market Limiters
7.4 Competitive Market Share Analysis

8. Autologous Chondrocyte Implantation Market
8.1 Introduction
8.1.1
8.2 Market Analysis and Forecast
8.3 Drivers and Limiters
8.3.1.1 Market Drivers
8.3.1.2 Market Limiters
8.4 Competitive Market Share Analysis

9. Orthopedic Cell Therapy Market
9.1 Usa Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Total Orthopedic Cell Therapy Market
9.3.2 Total Platelet-Rich Plasma Market
9.3.2.1 Soft Tissue Platelet-Rich Plasma Market
9.3.2.2 Orthopedic Platelet-Rich Plasma Market
9.3.2.3 Cardiac Platelet-Rich Plasma Market
9.3.2.4 Spine Platelet-Rich Plasma Market
9.3.2.5 Plastics Platelet-Rich Plasma Market
9.3.3 Total Bone Marrow Concentrate Market
9.3.3.1 Spine Bone Marrow Concentrate Market
9.3.3.2 Trauma Bone Marrow Concentrate Market
9.3.3.3 Soft Tissue Concentrated Bone Marrow Aspirate Market
9.3.3.4 Joint Concentration Bone Marrow Concentrate Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Fidia
  • Medtronic
  • TRB Chemedica
  • Meda Pharma
  • Sanofi Genzyme
  • Depuy Synthes
  • Bioventus
  • Laboratoire Genevrier
  • Recordati
  • Stryker
  • RTI Biologics
  • Croma-Pharma
  • Zimmer Biomet
  • Anika Therapeutics
  • Bioiberica
  • Documedica
  • Ferring
  • Geistlich
  • Integra Biologics
  • Kuros
  • LCA Pharma
  • Orotech
  • Plasmaconcept AG
  • Stella Pharmaceuticals
  • Alphatec Spine
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll